Europace

Oral Session

Clinical aspects and results of catheter ablations: 6 Catheter ablation effect on inflammation in atrial flutter patients
Europace 2005 7: 1; doi:10.1093/europace/7.s1.1 [PDF] [Request Permissions]  

Clinical aspects and results of catheter ablations: 7 Paroxysmal versus persistent atrial flutter: comparison of clinical, echocardiographical and electrophysiological parameters
Europace 2005 7: 1; doi:10.1093/europace/7.s1.1-a [PDF] [Request Permissions]  

Clinical aspects and results of catheter ablations: 8 Natural history of Wolff-Parkinson-White syndrome. Insights for risk stratification and management
Europace 2005 7: 1; doi:10.1093/europace/7.s1.1-b [PDF] [Request Permissions]  

Clinical aspects and results of catheter ablations: 9 Long-term outcome of radiofrequency ablation in patients with incessant ventricular tachycardias related to coronary artery disease
Europace 2005 7: 2; doi:10.1093/europace/7.s1.2 [PDF] [Request Permissions]  

Clinical aspects and results of catheter ablations: 10 Long-term prognosis in patients following catheter ablation for bundle branch reentry ventricular tachycardia
Europace 2005 7: 2; doi:10.1093/europace/7.s1.2-a [PDF] [Request Permissions]  

Clinical aspects and results of catheter ablations: 11 Left ventricular coronary vein mapping in patients with frequent VTs or VT storm
Europace 2005 7: 2; doi:10.1093/europace/7.s1.2-b [PDF] [Request Permissions]  

Catheter ablation and atrial fibrillation: the days and months after: 35 Evaluation of asymptomatic atrial fibrillation recurrences: CACAF study
Europace 2005 7: 3; doi:10.1093/europace/7.s1.3 [PDF] [Request Permissions]  

Catheter ablation and atrial fibrillation: the days and months after: 36 Paroxysmal atrial fibrillation: long-term results of different ablation strategies according to different arrhythmic patterns
Europace 2005 7: 3; doi:10.1093/europace/7.s1.3-a [PDF] [Request Permissions]  

Catheter ablation and atrial fibrillation: the days and months after: 37 Recurrence of atrial fibrillation after efficacious radiofrequency transcatheter ablation of regular supraventricular tachycardia
Europace 2005 7: 3-4; doi:10.1093/europace/7.s1.3-b [PDF] [Request Permissions]  

Catheter ablation and atrial fibrillation: the days and months after: 38 Change of AF variability and change of AF perception after catheter ablation. Implications on follow-up
Europace 2005 7: 4; doi:10.1093/europace/7.s1.4 [PDF] [Request Permissions]  

Catheter ablation and atrial fibrillation: the days and months after: 39 Electrophysiological findings during reablation for recurrence of intermittent atrial fibrillation after pulmonary vein isolation with electroanatomic encircling
Europace 2005 7: 4; doi:10.1093/europace/7.s1.4-a [PDF] [Request Permissions]  

Catheter ablation and atrial fibrillation: the days and months after: 40 Long-term follow-up of patients after radiofrequency catheter ablation of atrial fibrillation
Europace 2005 7: 4; doi:10.1093/europace/7.s1.4-b [PDF] [Request Permissions]  

Outcome of pacing in different indications: 24 Permanent direct His bundle pacing does not induce ventricular dyssynchrony as opposed to conventional right ventricular apical DDD pacing
Europace 2005 7: 5; doi:10.1093/europace/7.s1.5 [PDF] [Request Permissions]  

Outcome of pacing in different indications: 25 Determining optimal dual chamber algorithm to favor spontaneous AV conduction: preliminary results of the Saver study
Europace 2005 7: 5; doi:10.1093/europace/7.s1.5-a [PDF] [Request Permissions]  

Outcome of pacing in different indications: 26 Permanent pacemaker implantation following cardiac surgery: indications and long term follow up
Europace 2005 7: 5-6; doi:10.1093/europace/7.s1.5-b [PDF] [Request Permissions]  

Outcome of pacing in different indications: 27 Long-term results of VVI and DDD pacing modes in patients with sick sinus syndrome
Europace 2005 7: 6; doi:10.1093/europace/7.s1.6 [PDF] [Request Permissions]  

Outcome of pacing in different indications: 28 Biventricular pacing versus DDD(R) pacing in patients with high-grade AV-block. A randomized comparison
Europace 2005 7: 6; doi:10.1093/europace/7.s1.6-a [PDF] [Request Permissions]  

Outcome of pacing in different indications: 29 Clinical importance of permanent pacemaker mode selection in patients with complete atrioventricular block
Europace 2005 7: 6; doi:10.1093/europace/7.s1.6-b [PDF] [Request Permissions]  

Non-invasive risk stratification for ventricular tachycardia: 30 Predictors of mortality in patients with left ventricular dysfunction after coronary bypass surgery: results of 5 years prospective study
Europace 2005 7: 7; doi:10.1093/europace/7.s1.7 [PDF] [Request Permissions]  

Non-invasive risk stratification for ventricular tachycardia: 31 T-wave loop and QRS complex loop variables and mortality in postinfarction patients
Europace 2005 7: 7; doi:10.1093/europace/7.s1.7-a [PDF] [Request Permissions]  

Non-invasive risk stratification for ventricular tachycardia: 32 Value of microvoltage T-wave alternans to predict ventricular arrhythmia recurrence in ICD patients
Europace 2005 7: 7-8; doi:10.1093/europace/7.s1.7-b [PDF] [Request Permissions]  

Non-invasive risk stratification for ventricular tachycardia: 33 Mechanisms of the onset and circadian rhythm of ventricular tachyarrhythmias in patients under cardiac resynchronization therapy
Europace 2005 7: 8; doi:10.1093/europace/7.s1.8 [PDF] [Request Permissions]  

Non-invasive risk stratification for ventricular tachycardia: 34 Risk stratification in patients with Brugada syndrome. Analysis of daily variations in 12-lead electrocardiogram (ECG) and signal-averaged electrocardiogram (SAECG)
Europace 2005 7: 8; doi:10.1093/europace/7.s1.8-a [PDF] [Request Permissions]  

Coronary sinus lead placement: imaging and tools for implantation: 45 Feasibility of cardiac CT for detecting the optimum coronary sinus branch in cardiac resynchronized therapy
Europace 2005 7: 8-9; doi:10.1093/europace/7.s1.8-b [PDF] [Request Permissions]  

Coronary sinus lead placement: imaging and tools for implantation: 46 Non-invasive visualization of the cardiac venous system using multi-slice computed tomography
Europace 2005 7: 9; doi:10.1093/europace/7.s1.9 [PDF] [Request Permissions]  

Coronary sinus lead placement: imaging and tools for implantation: 47 Coronary venous anatomy and transvenous lead placement at the left ventricular lateral wall
Europace 2005 7: 9; doi:10.1093/europace/7.s1.9-a [PDF] [Request Permissions]  

Coronary sinus lead placement: imaging and tools for implantation: 48 Left ventricular lead placement within a coronary sinus side branch is feasible using remote magnetic navigation of a guidewire
Europace 2005 7: 9; doi:10.1093/europace/7.s1.9-b [PDF] [Request Permissions]  

Coronary sinus lead placement: imaging and tools for implantation: 49 Coronarsinus — Vein — Angioplasty for Implantation of Left Ventricular Leads in Cardiac Resynchronization Therapy
Europace 2005 7: 10; doi:10.1093/europace/7.s1.10 [PDF] [Request Permissions]  

Coronary sinus lead placement: imaging and tools for implantation: 50 Stabilization of the coronary sinus electrode position with stent implantation: a new technique for prevention and treatment of lead dislocation
Europace 2005 7: 10; doi:10.1093/europace/7.s1.10-a [PDF] [Request Permissions]  

New indications in cardiac resynchronisation therapy: 75 Sleep disorder breathing and heart failure: role of biventricular pacing
Europace 2005 7: 10-11; doi:10.1093/europace/7.s1.10-b [PDF] [Request Permissions]  

New indications in cardiac resynchronisation therapy: 76 Long-term outcome of heart failure patients treated with cardiac resynchronization therapy: a comparison between diabetic and non-diabetic patients
Europace 2005 7: 11; doi:10.1093/europace/7.s1.11 [PDF] [Request Permissions]  

New indications in cardiac resynchronisation therapy: 77 Cardiac Resynchronization Therapy in very old patients: the InSync/InSync ICD Italian registries
Europace 2005 7: 11; doi:10.1093/europace/7.s1.11-a [PDF] [Request Permissions]  

New indications in cardiac resynchronisation therapy: 78 Cardiac resynchronization therapy in NYHA II patients: the Insync/Insync ICD Italian registries
Europace 2005 7: 12; doi:10.1093/europace/7.s1.12 [PDF] [Request Permissions]  

New indications in cardiac resynchronisation therapy: 79 Congestive heart failure, atrial fibrillation, chronic RV-pacing and cardiac resynchronization therapy
Europace 2005 7: 12; doi:10.1093/europace/7.s1.12-a [PDF] [Request Permissions]  

New indications in cardiac resynchronisation therapy: 80 Adult congenital heart disease patients with systemic right ventricle: potential candidates for cardiac resynchronisation therapy
Europace 2005 7: 12-13; doi:10.1093/europace/7.s1.12-b [PDF] [Request Permissions]  

Clinical implications of QT internal measurements: 63 Corrected QT interval predicts mortality in patients with non-Q-wave anterior wall myocardial infarction
Europace 2005 7: 13; doi:10.1093/europace/7.s1.13 [PDF] [Request Permissions]  

Clinical implications of QT internal measurements: 64 QT interval variability and QT/RR relationship in patients with postinfarction impairment of the left ventricle function and different types of ventricular arrhythmias
Europace 2005 7: 13; doi:10.1093/europace/7.s1.13-a [PDF] [Request Permissions]  

Clinical implications of QT internal measurements: 65 Repolarization parameters in patients with acute anterior myocardial infarction treated with primary PTCA: relationship with the myocardial perfusion
Europace 2005 7: 13-14; doi:10.1093/europace/7.s1.13-b [PDF] [Request Permissions]  

Clinical implications of QT internal measurements: 66 Increased dispersion of the repolarization during recovery from exercise
Europace 2005 7: 14; doi:10.1093/europace/7.s1.14 [PDF] [Request Permissions]  

Clinical implications of QT internal measurements: 67 Individual QT/RR relationship: average stability over time does not rule out an individual residual variability implication for the assessment of drug effect on the QT interval
Europace 2005 7: 14; doi:10.1093/europace/7.s1.14-a [PDF] [Request Permissions]  

Clinical implications of QT internal measurements: 68 Comparison of the effects of a selective If current inhibitor ivabradine and atenolol on the QT interval in patients with coronary artery disease
Europace 2005 7: 14-15; doi:10.1093/europace/7.s1.14-b [PDF] [Request Permissions]  

Basic aspects of atrial and ventricular arrhythmias: 69 T97C and C193T substitutions in KCNE5: two genetic risk factors for atrial fibrillation
Europace 2005 7: 15; doi:10.1093/europace/7.s1.15 [PDF] [Request Permissions]  

Basic aspects of atrial and ventricular arrhythmias: 70 Neurally induced atrial arrhythmias are eliminated by alpha-adrenergic blockade
Europace 2005 7: 15; doi:10.1093/europace/7.s1.15-a [PDF] [Request Permissions]  

Basic aspects of atrial and ventricular arrhythmias: 71 Infarct healing and arrhythmias affected by gap junction remodelling in Cx43-deficient mice
Europace 2005 7: 16; doi:10.1093/europace/7.s1.16 [PDF] [Request Permissions]  

Basic aspects of atrial and ventricular arrhythmias: 72 Conduction delay plays a key role in predisposing the heart to ventricular fibrillation in acute regional ischemia
Europace 2005 7: 16; doi:10.1093/europace/7.s1.16-a [PDF] [Request Permissions]  

Basic aspects of atrial and ventricular arrhythmias: 73 Effect of hypothermia on action potential duration restitution and initiation of ventricular arrhythmias in mouse hearts: an optical mapping study
Europace 2005 7: 16; doi:10.1093/europace/7.s1.16-b [PDF] [Request Permissions]  

Basic aspects of atrial and ventricular arrhythmias: 74 Development of the right ventricular inflow tract and moderator band as a morphological substrate for mahaim tachycardia
Europace 2005 7: 17; doi:10.1093/europace/7.s1.17 [PDF] [Request Permissions]  

Award session: 93 Results of simultaneous electrophysiologic investigation in 105 prospective HOCM patients during transcoronary ablation of septal hypertrophy (TASH)
Europace 2005 7: 54; doi:10.1093/europace/7.s1.54 [PDF] [Request Permissions]  

Award session: 94 Assessment of atrial overdrive pacing as a treatment for patients with obstructive sleep Apnoea Hypopnoea Syndrome
Europace 2005 7: 54; doi:10.1093/europace/7.s1.54-a [PDF] [Request Permissions]  

Award session: 95 Early recovery of pulmonary vein potentials does not necessarily predict long-term recurrence of atrial fibrillation
Europace 2005 7: 54-55; doi:10.1093/europace/7.s1.54-b [PDF] [Request Permissions]  

Award session: 96 The fortuitous individual with a Brugada-like electrocardiogram
Europace 2005 7: 55; doi:10.1093/europace/7.s1.55 [PDF] [Request Permissions]  

Award session: 97 Selective activation of epsilon-PKC in transgenic mice protects against ischemia related reperfusion arrhythmias
Europace 2005 7: 55; doi:10.1093/europace/7.s1.55-a [PDF] [Request Permissions]  

Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 122 Is the unipolar or the bipolar mode more energy efficient in biventricular pacemakers?
Europace 2005 7: 55-56; doi:10.1093/europace/7.s1.55-b [PDF] [Request Permissions]  

Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 123 Cardiac Resynchronization Therapy with an implantable cardiac defibrillator: comparison between transvenous approach and epimyocardial approach for left ventricular lead placement
Europace 2005 7: 56; doi:10.1093/europace/7.s1.56 [PDF] [Request Permissions]  

Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 124 Anodal stimulation hinders V-V timing with pacing of the left ventricle first at long V-V intervals but causes triple site ventricular pacing at short V-V intervals
Europace 2005 7: 56; doi:10.1093/europace/7.s1.56-a [PDF] [Request Permissions]  

Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 125 Evaluation of biventricular capture detection using the paced depolarization integral (PDI) method in the chronic canine
Europace 2005 7: 56-57; doi:10.1093/europace/7.s1.56-b [PDF] [Request Permissions]  

Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 126 BiV capture verification utilizing RV coil to can evoked response in CRT-D patients
Europace 2005 7: 57; doi:10.1093/europace/7.s1.57 [PDF] [Request Permissions]  

Resynchronisation therapy: left ventricular implantations and new approaches, new stimulation techniques: 127 Biventricular auto capture is feasible in CHF patients with LBBB
Europace 2005 7: 57; doi:10.1093/europace/7.s1.57-a [PDF] [Request Permissions]  

Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 110 Benefits of cardiac resynchronization therapy extend to patients up-graded from right ventricular to biventricular pacing
Europace 2005 7: 57-58; doi:10.1093/europace/7.s1.57-b [PDF] [Request Permissions]  

Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 111 In patients with dilated cardiomyopathy and ventricular dyssynchrony, upgrading to cardiac resynchronization is beneficial as de novo implant
Europace 2005 7: 58; doi:10.1093/europace/7.s1.58 [PDF] [Request Permissions]  

Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 112 Biventricular or right ventricular permanent pacing after atrioventricular nodal ablation in patients with advanced heart failure and chronic atrial fibrillation
Europace 2005 7: 58; doi:10.1093/europace/7.s1.58-a [PDF] [Request Permissions]  

Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 113 Upgrading from right conventional ventricular pacing to biventricular pacing: hemodynamic benefits and technical issues
Europace 2005 7: 58-59; doi:10.1093/europace/7.s1.58-b [PDF] [Request Permissions]  

Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 114 Upgrade to biventricular pacing device of pacemaker holders for antibradycardia indications: the Insync/Insync ICD italian registries
Europace 2005 7: 59; doi:10.1093/europace/7.s1.59 [PDF] [Request Permissions]  

Heart failure patients with cardiac pacing: results of upgrading to cardiac resynchronisation therapy: 115 Patients with right ventricular apical pacing and drug refractory heart failure benefit significantly from cardiac resynchronization therapy
Europace 2005 7: 59; doi:10.1093/europace/7.s1.59-a [PDF] [Request Permissions]  

Heart rate turbulence: 116 Heart Rate Turbulence is more suitable than Heart Rate Variability to detect transient autonomic changes preceding ventricular arrhythmias
Europace 2005 7: 59-60; doi:10.1093/europace/7.s1.59-b [PDF] [Request Permissions]  

Heart rate turbulence: 117 "Heart rate turbulence" after short periods of spontaneous, non-sustained ventricular tachycardia and its relation with heart rate variability indexes
Europace 2005 7: 60; doi:10.1093/europace/7.s1.60 [PDF] [Request Permissions]  

Heart rate turbulence: 118 Heart rate turbulence in risk stratification of sudden cardiac death in myocardial infarction survivors - a prospective study
Europace 2005 7: 60; doi:10.1093/europace/7.s1.60-a [PDF] [Request Permissions]  

Heart rate turbulence: 119 The influence of some clinical data in patients with acute myocardial infarction on heart rate turbulence parameters
Europace 2005 7: 61; doi:10.1093/europace/7.s1.61 [PDF] [Request Permissions]  

Heart rate turbulence: 120 Heart rate turbulence slope triggered by atrial premature complexes correlates with phenylephrine baroreflex sensitivity in the ATRAMI study
Europace 2005 7: 61; doi:10.1093/europace/7.s1.61-a [PDF] [Request Permissions]  

Heart rate turbulence: 121 Heart Rate Turbulence in patients with myotonic dystrophy type 1: a new marker for arrhythmic risk stratification
Europace 2005 7: 61-62; doi:10.1093/europace/7.s1.61-b [PDF] [Request Permissions]  

Pulmonary vein ablation and complications: how to avoid?: 279 Regression of phrenic nerve injury after AF ablation
Europace 2005 7: 62; doi:10.1093/europace/7.s1.62 [PDF] [Request Permissions]  

Pulmonary vein ablation and complications: how to avoid?: 280 Pulmonary vein stenosis after ostial cryoisolation in patients with atrial fibrillation?
Europace 2005 7: 62; doi:10.1093/europace/7.s1.62-a [PDF] [Request Permissions]  

Pulmonary vein ablation and complications: how to avoid?: 281 Incidence of asymptomatic pulmonary vein stenosis in atrial fibrillation ablation. Segmental ostial ablation versus pulmonary veins encircling
Europace 2005 7: 62-63; doi:10.1093/europace/7.s1.62-b [PDF] [Request Permissions]  

Pulmonary vein ablation and complications: how to avoid?: 282 Recognition of phrenic nerve location for ablation at right pulmonary vein and superior vena cava
Europace 2005 7: 63; doi:10.1093/europace/7.s1.63 [PDF] [Request Permissions]  

Pulmonary vein ablation and complications: how to avoid?: 283 Oesophageal Tagging: a new method to prevent oesophagus perforation during AF ablation
Europace 2005 7: 63; doi:10.1093/europace/7.s1.63-a [PDF] [Request Permissions]  

Pulmonary vein ablation and complications: how to avoid?: 284 Where is the esophagus? Anatomical implications for ablation of atrial fibrillation
Europace 2005 7: 63-64; doi:10.1093/europace/7.s1.63-b [PDF] [Request Permissions]  

Long-term follow up of CRT: effects on arrhythmogenesis: 267 Acute and mid-term effect of cardiac resynchronization therapy on mitral regurgitation in patients with severe chronic heart failure
Europace 2005 7: 64; doi:10.1093/europace/7.s1.64 [PDF] [Request Permissions]  

Long-term follow up of CRT: effects on arrhythmogenesis: 268 Biventricular pacing in right bundle-branch block
Europace 2005 7: 64; doi:10.1093/europace/7.s1.64-a [PDF] [Request Permissions]  

Long-term follow up of CRT: effects on arrhythmogenesis: 269 Cardiac resynchronization therapy does not reduce the incidence of ventricular arrhythmias
Europace 2005 7: 64-65; doi:10.1093/europace/7.s1.64-b [PDF] [Request Permissions]  

Long-term follow up of CRT: effects on arrhythmogenesis: 270 Left ventricular remodeling after cardiac resynchronization therapy reduces inducibility of ventricular tachy-arrhythmias
Europace 2005 7: 65; doi:10.1093/europace/7.s1.65 [PDF] [Request Permissions]  

Long-term follow up of CRT: effects on arrhythmogenesis: 271 Cardiac re-synchronization may have a beneficial effect on right ventricular mechanical performance
Europace 2005 7: 65; doi:10.1093/europace/7.s1.65-a [PDF] [Request Permissions]  

Long-term follow up of CRT: effects on arrhythmogenesis: 272 Clinical parameter variation in stable heart failure patients with a resynchronization device
Europace 2005 7: 65; doi:10.1093/europace/7.s1.65-b [PDF] [Request Permissions]  

ICD therapy in genetic cardiac disease: 273 ICD-therapy in hypertrophic cardiomyopathy: discharge rates of 42 pts in a 2 year follow-up
Europace 2005 7: 66; doi:10.1093/europace/7.s1.66 [PDF] [Request Permissions]  

ICD therapy in genetic cardiac disease: 274 Collective Observatory of BRugadA syndrome (COBRA): a French national multicenter survey
Europace 2005 7: 66; doi:10.1093/europace/7.s1.66-a [PDF] [Request Permissions]  

ICD therapy in genetic cardiac disease: 275 Long-term prognosis of individuals with right precordial ST-elevation - Brugada syndrome
Europace 2005 7: 66-67; doi:10.1093/europace/7.s1.66-b [PDF] [Request Permissions]  

ICD therapy in genetic cardiac disease: 276 Clinical follow-up of patients with Short QT syndrome
Europace 2005 7: 67; doi:10.1093/europace/7.s1.67 [PDF] [Request Permissions]  

ICD therapy in genetic cardiac disease: 277 Outcome in patients with arrhythmogenic right ventricular dysplasia and implantable cardioverter-defibrillators
Europace 2005 7: 67; doi:10.1093/europace/7.s1.67-a [PDF] [Request Permissions]  

ICD therapy in genetic cardiac disease: 278 Sudden cardiac death in the young: is prevention by prospective evaluation feasible?
Europace 2005 7: 67; doi:10.1093/europace/7.s1.67-b [PDF] [Request Permissions]  

New insights in catheter ablation of ventricular arrhythmia: 331 Catheter ablation of idiopathic multifocal premature ventricular contractions
Europace 2005 7: 101; doi:10.1093/europace/7.s1.101 [PDF] [Request Permissions]  

New insights in catheter ablation of ventricular arrhythmia: 332 Clinical implication of presystolic bipolar potential for successful ablation of ventricular tachycardia originating from the aortic sinus cusp
Europace 2005 7: 101; doi:10.1093/europace/7.s1.101-a [PDF] [Request Permissions]  

New insights in catheter ablation of ventricular arrhythmia: 333 Substrate modification in ischaemic cardiomyopathy to treat ventricular tachycardia using electroanatomic scar mapping
Europace 2005 7: 101-102; doi:10.1093/europace/7.s1.101-b [PDF] [Request Permissions]  

New insights in catheter ablation of ventricular arrhythmia: 334 Localization of the critical isthmus of post-infarct reentrant ventricular tachycardia using sinus rhythm electrogram characteristics
Europace 2005 7: 102; doi:10.1093/europace/7.s1.102 [PDF] [Request Permissions]  

New insights in catheter ablation of ventricular arrhythmia: 335 Ablation of unmappable post-MI ventricular tachycardia using voltage-map in sinus rhythm
Europace 2005 7: 102; doi:10.1093/europace/7.s1.102-a [PDF] [Request Permissions]  

New insights in catheter ablation of ventricular arrhythmia: 336 Subendocardial conduction in normal and infarcted human hearts: re-evaluation of an old concept to guide ventricular tachycardia ablation during sinus rhythm
Europace 2005 7: 102-103; doi:10.1093/europace/7.s1.102-b [PDF] [Request Permissions]  

Atrial tissue ablation: from flutter to atrial tachycardia: 319 Temporal pattern of conduction recurrence during radiofrequency ablation for typical atrial flutter
Europace 2005 7: 103; doi:10.1093/europace/7.s1.103 [PDF] [Request Permissions]  

Atrial tissue ablation: from flutter to atrial tachycardia: 320 Early isthmus conduction recovery in atrial flutter ablation
Europace 2005 7: 103; doi:10.1093/europace/7.s1.103-a [PDF] [Request Permissions]  

Atrial tissue ablation: from flutter to atrial tachycardia: 321 The incidence of fractionated electrograms decreases with increasing distance from the origin of focal atrial tachycardias
Europace 2005 7: 103-104; doi:10.1093/europace/7.s1.103-b [PDF] [Request Permissions]  

Atrial tissue ablation: from flutter to atrial tachycardia: 322 Characteristic of focal atrial tachycardia arising from crista terminalis or coronary sinus with multiple activation sequences
Europace 2005 7: 104; doi:10.1093/europace/7.s1.104 [PDF] [Request Permissions]  

Atrial tissue ablation: from flutter to atrial tachycardia: 323 Mechanisms of right atrial tachycardia occurring late after surgical closure of atrial septal defects
Europace 2005 7: 104; doi:10.1093/europace/7.s1.104-a [PDF] [Request Permissions]  

Atrial tissue ablation: from flutter to atrial tachycardia: 324 Incidence and long-term outcome of atrial flutter occurring in the post-operative course of non congenital cardiac surgery: is radiofrequency ablation immediately indicated?
Europace 2005 7: 104; doi:10.1093/europace/7.s1.104-b [PDF] [Request Permissions]  

Optimisation of ICD therapy — DFT how to reduce it?: 325 The quick implantable cardioverter defibrillator trial (Quick-ICD) is an EPS and a DFT-testing still mandatory in patients with an indication for ICD-implantation?
Europace 2005 7: 105; doi:10.1093/europace/7.s1.105 [PDF] [Request Permissions]  

Optimisation of ICD therapy — DFT how to reduce it?: 326 Antitachycardia burst pacing in spontaneous ventricular tachycardias: how many pacing sequences should be programmed?
Europace 2005 7: 105; doi:10.1093/europace/7.s1.105-a [PDF] [Request Permissions]  

Optimisation of ICD therapy — DFT how to reduce it?: 327 ICD patients with elevated defibrillation threshold: clinical behavior and therapeutic alternatives
Europace 2005 7: 105; doi:10.1093/europace/7.s1.105-b [PDF] [Request Permissions]  

Optimisation of ICD therapy — DFT how to reduce it?: 328 Reduced defibrillation energy by vagal stimulation
Europace 2005 7: 105-106; doi:10.1093/europace/7.s1.105-c [PDF] [Request Permissions]  

Optimisation of ICD therapy — DFT how to reduce it?: 329 Regional programming differences in the worldwide empiric trial
Europace 2005 7: 106; doi:10.1093/europace/7.s1.106 [PDF] [Request Permissions]  

Optimisation of ICD therapy — DFT how to reduce it?: 330 Standardized extensive ATP programming reduces shocks for VT/VF compared to usual physician programming: results from the EMPIRIC trial
Europace 2005 7: 106-107; doi:10.1093/europace/7.s1.106-a [PDF] [Request Permissions]  

Mechanisms of atrial fibrillation: 476 Chronic left atrial volume and pressure overload in the goat: a new model of sustained atrial fibrillation
Europace 2005 7: 107; doi:10.1093/europace/7.s1.107 [PDF] [Request Permissions]  

Mechanisms of atrial fibrillation: 477 Effect of chronic amiodarone therapy on the excitable gap during typical human atrial flutter
Europace 2005 7: 107; doi:10.1093/europace/7.s1.107-a [PDF] [Request Permissions]  

Mechanisms of atrial fibrillation: 478 The role of matrix metalloproteinases in the development of atrial fibrillation
Europace 2005 7: 107-108; doi:10.1093/europace/7.s1.107-b [PDF] [Request Permissions]  

Mechanisms of atrial fibrillation: 479 Role of Bachmann's bundle during chronic atrial fibrillation in patients with mitral valve disease
Europace 2005 7: 108; doi:10.1093/europace/7.s1.108 [PDF] [Request Permissions]  

Mechanisms of atrial fibrillation: 480 RR intervals have an individually specific pattern in atrial fibrillation
Europace 2005 7: 108; doi:10.1093/europace/7.s1.108-a [PDF] [Request Permissions]  

Mechanisms of atrial fibrillation: 481 Posterior wall of left atrium and pulmonary veins refractory period is related to atrial fibrillation inducibility in pigs
Europace 2005 7: 108; doi:10.1093/europace/7.s1.108-b [PDF] [Request Permissions]  

Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 464 Tissue Doppler imaging predicts improvement in left ventricular performance and cardiac synchrony after biventricular pacing in advanced heart failure
Europace 2005 7: 109; doi:10.1093/europace/7.s1.109 [PDF] [Request Permissions]  

Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 465 Biventricular pacing in heart failure. An echocardiographic method to identify the long term "responders"
Europace 2005 7: 109; doi:10.1093/europace/7.s1.109-a [PDF] [Request Permissions]  

Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 466 Reverse left ventricular remodeling after cardiac resynchronization therapy is predicted by electrocardiographic and electrophysiological parameters
Europace 2005 7: 109-110; doi:10.1093/europace/7.s1.109-b [PDF] [Request Permissions]  

Electrical and mechanical predictors in response to cardiac resynchronisation therapy: 467 Cardiac resynchronization in long term follow up: analysis of clinical response predictors
Europace 2005 7: 110; doi:10.1093/europace/7.s1.110